Cart
sales@molnova.com
CTB
CAS No. 451491-47-7
CTB ( Cholera Toxin B subunit )
Catalog No. M28749 CAS No. 451491-47-7
CTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 53 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 295 | Get Quote |
|
| 100MG | 475 | Get Quote |
|
| 500MG | 1017 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCTB
-
NoteResearch use only, not for human use.
-
Brief DescriptionCTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.
-
DescriptionCTB (Cholera Toxin B subunit) is an activator of p300 histone acetyltransferase and induces apoptosis in MCF-7 cells.(In Vitro):dose-dependent.
-
SynonymsCholera Toxin B subunit
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorD2 receptor;5-HT2A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number451491-47-7
-
Formula Weight686.5
-
Molecular FormulaC32H25Cl2F6N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCOc(cccc1)c1C(Nc(cc1)cc(C(F)(F)F)c1Cl)=OCCOc(cccc1)c1C(Nc(cc1)cc(C(F)(F)F)c1Cl)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schotte A, et al. In vitro receptor binding and in vivo receptor occupancy in rat and guinea pig brain: risperidone compared with antipsychotics hitherto used. Jpn J Pharmacol. 1995 Dec;69(4):399-412.
molnova catalog
related products
-
J147
J-147 is a broad spectrum neuroprotective phenyl hydrazide compound(EC50=60-115 nM) with significant neurotrophic properties related to the induction of brain-derived neurotrophic factor (BDNF).
-
Escitalopram Oxalate
Escitalopram Oxalate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) with Ki of 0.89 nM.
-
SGC-SMARCA-BRDVIII
SGC-SMARCA-BRDVIII is a potent and selective inhibitor of SMARCA2, SMARCA4, PB1(2), PB1(3) and PB1(5) with Kds of 35 nM, 36 nM, 3.7 μM, 2.0 μM and 13 nM, respectively.
